ustekinumab-auub

ustekinumab-auub (WEZLANA) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous, subcutaneous. Current US regulatory status: approved.

WEZLANA is a marketed brand name for ustekinumab-auub. Check FDA Drugs@FDA for the current US label holder and prescribing information.

ustekinumab-auub has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.